ML141 10mg | ≥98%
CSNpharm
ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.
More Information Supplier PageML141
Search Results
ML141 5mg | ≥98%
CSNpharm
ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.
More Information Supplier PageML141
ML141 100mg | ≥98%
CSNpharm
ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.
More Information Supplier PageML141
ML141 50mg | ≥98%
CSNpharm
ML141 is a reversible and selective inhibitor of Cdc42 GTPase with IC50 of 200 nM.
More Information Supplier PageML141
Ifosfamide 250mg | ≥98%
CSNpharm
Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.
More Information Supplier PageIfosfamide
Ifosfamide 50mg | ≥98%
CSNpharm
Ifosfamide is a nitrogen mustard alkylating agent used in the treatment of cancer.
More Information Supplier PageIfosfamide
SJB2-043 1mg | ≥98%
CSNpharm
SJB2-043 is an inhibitor of ubiquitin-specific protease 1 (USP1) and it is one of derivatives of C527.
More Information Supplier PageSJB2-043
SJB2-043 100mg | ≥98%
CSNpharm
SJB2-043 is an inhibitor of ubiquitin-specific protease 1 (USP1) and it is one of derivatives of C527.
More Information Supplier PageSJB2-043
SJB2-043 50mg | ≥98%
CSNpharm
SJB2-043 is an inhibitor of ubiquitin-specific protease 1 (USP1) and it is one of derivatives of C527.
More Information Supplier PageSJB2-043
SJB2-043 5mg | ≥98%
CSNpharm
SJB2-043 is an inhibitor of ubiquitin-specific protease 1 (USP1) and it is one of derivatives of C527.
More Information Supplier PageSJB2-043